Predictors of outcome following psychological therapy for depression and anxiety in an urban primary care service: a naturalistic Bayesian prediction modeling approach
Almost a third of the variance in clinical outcomes was explained by pre-treatment symptom severity scores. These constructs benefit from being rapidly accessible in healthcare services. If replicated in external samples, the early identification of patients who are less likely to recover may facilitate earlier triage to alternative interventions.
Authors
- Matthew H. Hotopf (ORCID: https://orcid.org/0000-0002-3980-4466)
- André Tylee (ORCID: https://orcid.org/0000-0002-7899-408X)
- Janet Wingrove
- John Hodsoll (ORCID: https://orcid.org/0000-0001-7546-9901)
- Nina Grant (ORCID: https://orcid.org/0000-0002-8523-5276)
- Gerome D. Breen (ORCID: https://orcid.org/0000-0003-2053-1792)
- Rebecca Strawbridge (ORCID: https://orcid.org/0000-0002-2984-1124)
- Paul Moran (ORCID: https://orcid.org/0000-0002-9257-8699)
- Nick Grey
- Sinéad King (ORCID: https://orcid.org/0000-0003-1718-7302)
- Viryanaga Kitsune
- Allan H. Young (ORCID: https://orcid.org/0000-0003-2291-6952)
- Nilay Hepgul (ORCID: https://orcid.org/0000-0002-5980-1457)
- R. Taylor (ORCID: https://orcid.org/0000-0001-6471-537X)
- Anthony J. Cleare (ORCID: https://orcid.org/0000-0002-6990-939X)
Institutions
- University of Sussex (GB)
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- Sussex Partnership NHS Foundation Trust (GB)
- University of Bristol (GB)
Publication Details
- Journal
- Psychological Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1017/s0033291724001582
- Citations
- 1
- Primary Topic
- Mental Health Treatment and Access
- Type
- article
- Field-Weighted Citation Impact
- 0.64
Funders
- Eli Lilly and Company
- Biogen
- South London and Maudsley NHS Foundation Trust
- Sunovion
- LivaNova
- National Institute for Health and Care Research
- Department of Health and Social Care
- King's College London
- University of Bristol
- H. Lundbeck A/S
- Allergan
- NIHR Maudsley Biomedical Research Centre